Raja Kumaraguru
Stock Analyst at Roth MKM
(n/a)
# 4,373
Out of 4,735 analysts
5
Total ratings
n/a
Success rate
-43.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Raja Kumaraguru
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAIN Rain Enhancement Technologies Holdco | Downgrades: Neutral | $1.2 | $4.20 | -71.43% | 1 | May 30, 2023 | |
| NLSP NLS Pharmaceutics AG | Initiates: Buy | $480 | $1.90 | +25,163.16% | 1 | Mar 12, 2021 | |
| CNSP CNS Pharmaceuticals | Initiates: Buy | $15,000 | $0.11 | +14,204,445.45% | 1 | Feb 2, 2021 | |
| FBRX Forte Biosciences | Initiates: Buy | $2,250 | $14.70 | +15,206.12% | 1 | Aug 28, 2020 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $210 | $31.68 | +562.88% | 1 | Feb 19, 2020 |
Rain Enhancement Technologies Holdco
May 30, 2023
Downgrades: Neutral
Price Target: $1.2
Current: $4.20
Upside: -71.43%
NLS Pharmaceutics AG
Mar 12, 2021
Initiates: Buy
Price Target: $480
Current: $1.90
Upside: +25,163.16%
CNS Pharmaceuticals
Feb 2, 2021
Initiates: Buy
Price Target: $15,000
Current: $0.11
Upside: +14,204,445.45%
Forte Biosciences
Aug 28, 2020
Initiates: Buy
Price Target: $2,250
Current: $14.70
Upside: +15,206.12%
Monopar Therapeutics
Feb 19, 2020
Initiates: Buy
Price Target: $210
Current: $31.68
Upside: +562.88%